Skip to main content
Clinical Trials/NCT03201315
NCT03201315
Completed
Not Applicable

The Incremental Risk of Intraoperative Fentanyl on PONV: A Modifiable Risk Without Drawbacks?

University Hospital, Basel, Switzerland1 site in 1 country363 target enrollmentJanuary 1, 2017
ConditionsPONV

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
PONV
Sponsor
University Hospital, Basel, Switzerland
Enrollment
363
Locations
1
Primary Endpoint
Any postoperative nausea and/or vomiting (PONV) within 24 hours after surgery
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The aim of this quality control study is to describe the presence and intensity of postoperative nausea and vomiting (PONV) and its correlation with intraoperative fentanyl dosing. Additionally, the investigators will examine pain scores.

Detailed Description

The primary aims of this quality control study are: 1. to determine whether there is an independent association between the intraoperative administration of fentanyl (both as a continuous and categorical variable) and PONV within 24 postoperative hours 2. determine whether or not the intraoperative fentanyl amount can be used to successfully restratify patients for PONV beyond the simplified Apfel score for PONV All required data is collected in regular daily practice. The following variables will be assessed by univariable models: Preoperative variables (e.g. patient characteristics) Surgical/Anesthesia variables (e.g. type/length of surgery, antiemetics) Outcome variables (PONV, worst pain as delineated in the outcomes section), Intraoperative fentanyl measured 1) as a continuous variable and 2) by predefined limits of 0 to 0.2mg, \>0.2-0.5mg, \>0.5 to 0.8mg, and \>8mg. Finally for the multivariable model, the investigators will adjust for confounders, specifically for sex (m/f), history (Hx) of PONV (y/n), Hx of motion sickness (y/n), current smoker (y/n), age (years), expected duration of surgery (min; \>60 min), postoperative opioids (y/n), the use of preemptive PONV Therapy (0,1,2 medications), propofol vs. inhalative agents (y/n), and surgery type (3 kinds) from the patient's electronic record. In the event that insufficient event rates are observed, we will collapse the variables into the simplified Apfel score to assess the independent value of fentanyl in predicting PONV. In addition to a logistic model as delineated above, we will conduct the following: 1. receiver operating characteristic (ROC) curves of the logistic model without fentanyl, with fentanyl (continuous), and with fentanyl (categorical). 2. additionally, ROCs of a simplified model using the Apfel score, the Apfel score with fentanyl (continous), and the Apfel score with fentanyl (categorical) will be made. Comparison of area under the receiver operating characteristics(AUROCs) by DeLong 3. net reclassification improvement (NRI) of both the logistic model with and without fentanyl as well as the Apfel score with and without fentanyl To assess pain and administered fentanyl, we will examine pain scores by the numeric rating scale (NRS).

Registry
clinicaltrials.gov
Start Date
January 1, 2017
End Date
May 2017
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Basel, Switzerland
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • In-patients with an expected simplified Apfel score of 2 or higher,
  • Aged \>= 18 years, and
  • Undergoing general anesthesia (with or without neuraxial or regional anesthesia.)
  • in abdominal, gynecological or otorhinolaryngological surgery

Exclusion Criteria

  • Outpatients
  • Patients with chronic pain, defined as recurring pain requiring intermittent hospitalization or regular intake of pain medication.
  • Non-opioid naïve patients, defined as a history of abuse or having taken opioids within the last 30 days

Outcomes

Primary Outcomes

Any postoperative nausea and/or vomiting (PONV) within 24 hours after surgery

Time Frame: within 24 hours (or next morning discharge)

postoperative nausea and/or vomiting (PONV) yes/no (either by chart or by patient confirmation) within 24 hours (or next morning discharge)

Secondary Outcomes

  • number of postoperative vomiting events within 24 hours(within 24 hours (or next morning discharge))
  • Any postoperative nausea and/or vomiting (PONV) while in the recovery room(first two postoperative hours)
  • Worst pain, i.e. highest Numeric Rating Score (NRS)(within 24 hours / in recovery room (first two postoperative hours))

Study Sites (1)

Loading locations...

Similar Trials